Accuray Inc last reported quarterly results on Nov 4, 2026, for Q1 FY2027 (the quarter ended Sep 30, 2026): revenue of $86.5 million (-7.9% year over year) and diluted EPS of $0.07. It usually reports 35–50 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 3, 2027.
Results for Q2 FY2027, the quarter ending around Dec 31, 2026. Expected on a Wednesday. Based on last year's release for the same quarter on Feb 4, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 35–50 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 4, 2026
35 days after quarter end
From press release
|
Q1 FY2027
ended Sep 30, 2026
|
87
-7.9%
|
10
+146.7%
|
0.07
+138.9%
|
|
Aug 19, 2026
50 days after quarter end
|
Q4 FY2026
ended Jun 30, 2026
|
101
-20.9%
|
-2
-272.8%
|
—
|
|
May 6, 2026
36 days after quarter end
|
Q3 FY2026
ended Mar 31, 2026
|
105
-7.4%
|
-12
-810.2%
|
—
|
|
Feb 4, 2026
35 days after quarter end
|
Q2 FY2026
ended Dec 31, 2025
|
102
-12.0%
|
-14
-642.8%
|
-0.11
-650.0%
|
|
Oct 20, 2025
20 days after quarter end
|
Q1 FY2026
ended Sep 30, 2025
|
94
|
-22
|
-0.18
+0.0%
|
|
Aug 13, 2025
44 days after quarter end
|
Q4 FY2025
ended Jun 30, 2025
|
128
-5.0%
|
1
-66.8%
|
0.01
-69.1%
|
|
Apr 30, 2025
30 days after quarter end
|
Q3 FY2025
ended Mar 31, 2025
|
113
+12.0%
|
-1
+79.5%
|
-0.01
+83.3%
|
|
Feb 5, 2025
36 days after quarter end
|
Q2 FY2025
ended Dec 31, 2024
|
116
+8.3%
|
3
+126.4%
|
0.02
+120.0%
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- ARAY (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Madison, WI
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1138723
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.